Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials

BACKGROUND: A network meta-analysis of randomized controlled trials (RCTs) was conducted to explore the cardiovascular outcomes of all the kind and dosages of sodium-glucose cotransport-2 (SGLT2) inhibitors in type 2 diabetes mellitus (T2DM) patients. METHOD AND RESULT: The Cochrane Library, PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yu, Yang, Pingping, Fu, Linghua, Sun, Lizhe, Shen, Wen, Wu, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967154/
https://www.ncbi.nlm.nih.gov/pubmed/35370961
http://dx.doi.org/10.3389/fendo.2022.802992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967154/
https://www.ncbi.nlm.nih.gov/pubmed/35370961
http://dx.doi.org/10.3389/fendo.2022.802992

Ejemplares similares